application note: crystal16 and solubility curves
TRANSCRIPT
The basics of solubility curves
• Solubilitydataareusedtomakecrucialdecisionsfromtheearliest
stagesofdrugdiscoveryandthroughouttheentiredevelopmentpro
cess.Asolubilitycurveshowshowthesolubilityofasubstancevaries
withtemperature.Thesubstancesaretypicallyfreebasesorsalts,and
waterisbyfarthemostcommonsolvent.Thesolubilityofasubstance
inwaterdependsonseveralfactors.
• Thesolidstatecharacteristicsofdrugsareknowntoexertapoten
tiallysignificantinfluenceonthesolubility.Polymorphsofadrug
substancecanhavedifferentmeasuredaqueoussolubilityanddissolu
tionrates.Whensuchdifferencesaresignificant,theirbioavailability
differs,inwhichcaseitmaybedifficulttoformulateabioequivalent
drugproductusinganalternativepolymorph.Whensolubilityand
dissolutionrateoftherelevantpolymorphic
formsaresufficientlyhigh,regulatorycon
cernswithrespecttobioavailabilityand
stabilityareminimal.Whendecidingwhich
polymorphtodevelopandregister,the
BiopharmaceuticsClassificationcriteria
ofhighsolubilityandrapiddissolution
shouldbeconsidered.
Efficient determination of solubility curves
• Experimentaldeterminationofsolubilitycurvestraditionallyrelies
onlaborintensivetechniques,whichiswhydetailedsolubilitydata
areoftennotavailable.TheCrystal16™combinesautomationwith
integratedturbiditymeasurementtodeterminecloudandclearpoints
andisideallysuitedtoacquiresolubilitydataatanearlystageusing
onlyminimalamountsofsample.
• Thesolubilitycurveisathermodynamicpropertyofthesubstance
solventsystem.Whenmeasuringthesolubilitycurveusingveryfast
heatingrates,itispossibletoovershoot,butatslowerratesthe
measuredclearpointshouldbeconstantirrespectiveofheating
rate.Aseriesofmeasurementswiththe
Crystal16™showthatheatingratesbelow
0.5°C/mingenerallyyieldconsistentclear
pointswhereasthesolubilitycurvecan
beeasilyovershotatheatingratesabove
5°C/min.
• UsingaCrystal16™with16vialsholding
4differentconcentrationsofadrug
substancein4differentsolventsand
applying2temperaturecycleswitha
heatingrateof0.5°C/minandacoolingrateof1°C/min,
4solubilitycurvescanbemeasuredinduplicateinhalfaday.
3 ApplicAtion note 3
Solubility data are used to make crucial decisions from the earliest
stages of drug discovery and throughout the entire development
process. The Crystal16™ and optional CrystalClear™ software provide
the ideal tools to efficiently gather and analyze solubility data at an early
stage, using only minimal amounts of sample. Discover why several pharmaceutical
companies have already chosen the Crystal16™ as their standard tool to determine
solubility of their drug compounds.
0
-10 0C 0 0C 10 0C 20 0C 30 0C 40 0C 50 0C 60 0C
10.00 min
1.00 min
0.10 min
0.01 min
60 0C 65 0C 70 0C 75 0C
Heat/Cool Rate (0C/min)
Concentration (mg/g)
Concentration (mg/g)
0
100
40
20
60
80
100
120
140
200
300
400
500
600
-10 0C 0 0C 10 0C 20 0C 30 0C 40 0C 50 0C 60 0C
Gravimetric
MethanolBlock A
Solvated
Anhydrous
iPropanolBlock C
EthanolBlock B
ApplicAtion notes
Crystal16 TM - 1
Polymorph and salt screening - 2
Solubility measurements - 3
Metastable zone width determination - 4
Co-crystallization studies - 5
Anti-solvents - 6
Fast track to return on investment - 7
Improve and accelerate your crystallization research
with the Crystal16™ parallel crystallizer, the ultimate
tool for solid-state research and process development.
Designed by scientists for scientists, the Crystal16™
is a user-friendly multi-reactor benchtop system with
intuitive software to perform medium-throughput
crystallization studies at a 1-ml scale. It offers
invaluable assistance throughout the various stages
of the drug development life cycle, from preclinical
screening to process optimization. Developed for
crystallization studies, the Crystal16™ has also been
successfully used in other application areas such as
polymer solubility studies and process chemistry.
Improve and accelerate
your crystallization research
Solubilitymeasurements
Examples
• APIsolubility
SeveralpharmaceuticalcompanieshavechosentheCrystal16™as
theirstandardtooltodeterminesolubility.Thegraphtotheright
showsthesolubilitycurvesofanAPIinthreesolvents,determinedon
theCrystal16™using3ofthe4blocks.Ineachoftheblocks4HPLC
vialswithdifferentconcentrationsoftheAPIwereheatedto60°C
at0.3°C/min.Thedataresultingfromtheexperimentscarriedout
ontheCrystal16™(fulllines)agreedwellwiththedataobtained
usingagravimetricmethod(dashedlines).
• APIinterconversions
Atypicalexperimentwouldconsistof(i)preparinganarrayofslurries
ofvaryingconcentrationsofsolidin1mlofasolventorsolvent
mixture,(ii)heatingto75°Cat0.3°C/min,usingmagneticstirbars
toagitatetheslurry,determiningthedissolutiontemperature
byturbiditymeasurements(iii)followedbycoolingto0°Cat
1°C/mintoobservecrystallizationofthesample,againbymeasuring
turbidity.Intheexampleshownopposite,eachmeasurementcycle
wasrepeated3timestoincreaseconfidenceintheresults.Inthefirst
measurementcycle,crystallizationofthesubstanceduringthecooling
cycleresultedinahydrateratherthantheanticipatedanhydrous
form.Consequently,adifferentsolubilitycurvewasobtainedinthe
subsequentmeasurementcycles.Thesolvatedformappearstobethe
thermodynamicallystableformbelow15°C(i.e.lowestsolubility).
Thisexampleillustratesthat(pseudo)polymorphicchangescanbe
inducedandobservedbyrepeatedmeasurementsofthesolubility
curve.Thesechangesmayprovidecrucialinformationfortheultimate
crystallizationprocessdevelopmentordownstreamoperations.
Inaddition,duplicateortriplicatemeasurementswillincrease
confidenceintheresults.
21st century manufacturing
Theapplicationofprocessanalyticaltechnology(PAT)tocrystallization
processdesignhasalwaysbeenanareaofhighinterestforboth
thechemicaldevelopmentandmanufacturingarenas.Thisispartly
duetothegrowingemphasisonPATasatoolfor‘21stCentury
Manufacturing’asdescribed,forexample,intheguidelinedocument
‘PATAFrameworkforInnovativePharmaceuticalDevelopment,
Manufacturing,andQualityAssurance’issuedbytheFDAin2004.
Theuseofinsituturbiditymeasurementandautomatedmethods
todeterminesolubilitycurvessignificantlyreducesoperatorworkload
comparedtotraditionalmethods,whichshouldencouragetheuseof
solubilitydataintheearlystagesofcrystallizationprocessdevelopment.
3
0
-10 0C 0 0C 10 0C 20 0C 30 0C 40 0C 50 0C 60 0C
10.00 min
1.00 min
0.10 min
0.01 min
60 0C 65 0C 70 0C 75 0C
Heat/Cool Rate (0C/min)
Concentration (mg/g)
Concentration (mg/g)
0
100
40
20
60
80
100
120
140
200
300
400
500
600
-10 0C 0 0C 10 0C 20 0C 30 0C 40 0C 50 0C 60 0C
Gravimetric
MethanolBlock A
Solvated
Anhydrous
iPropanolBlock C
EthanolBlock B
ApplicAtion notes
Crystal16 TM - 1
Polymorph and salt screening - 2
Solubility measurements - 3
Metastable zone width determination - 4
Co-crystallization studies - 5
Anti-solvents - 6
Fast track to return on investment - 7
1810 KSC Alkmaar
Please contact us for more information:
www.crystallizationsystems.com
are products and trademarks of
Technobis Crystallization Systems B.V.
Pyrietstraat 2
The Netherlands
Tel: +32 72 3020040
Crystal16™ and CrystalClear™
s t e p s a h e a d